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ABSTRACT
Objectives: To determine (1) reconsultation
frequency, (2) change in self-reported health status, (3)
baseline factors associated with reconsultation and
change in health status and (4) associated healthcare
costs and quality-adjusted life-years (QALYs), following
assessment at a musculoskeletal Clinical and
Assessment Treatment Service (CATS).
Design: Prospective cohort study.
Setting: Single musculoskeletal CATS at the primary–
secondary care interface.
Participants: 2166 CATS attenders followed-up by
postal questionnaires at 6 and 12 months and review
of medical records.
Outcome measures: Primary outcome was
consultation in primary care with the same
musculoskeletal problem within 12 months. Secondary
outcome measures were consultation at the CATS with
the same musculoskeletal problem within 12 months,
physical function and pain (Short Form-36), anxiety
and depression (Hospital Anxiety and Depression
Scale), time off work, healthcare costs and QALYs.
Results: Over 12 months, 507 (38%) reconsulted for
the same problem in primary care and 345 (26%) at
the CATS. Primary care reconsultation in the first
3 months was associated with baseline pain
interference (relative risk ratio 5.33; 95% CI 3.23 to
8.80) and spinal pain (1.75; 1.09 to 2.82), and after
3–6 months with baseline assessment by a hospital
specialist (2.06; 1.13 to 3.75). Small mean
improvements were seen in physical function (1.88;
95% CI 1.44 to 2.32) and body pain (3.86; 3.38 to
4.34) at 6 months. Poor physical function at 6 months
was associated with obesity, chronic pain and poor
baseline physical function. Mean (SD) 6-month cost
and QALYs per patient were £422.40 (660.11) and
0.257 (0.144), respectively.
Conclusions: While most patients are appropriate for
a ‘one-stop shop’ model, those with troublesome,
disabling pain and spinal pain commonly reconsult and
have ongoing problems. Services should be configured
to identify and address such clinical complexity.
INTRODUCTION
Musculoskeletal problems such as osteoarth-
ritis (OA) and back pain are highly prevalent
and present frequently to primary care.
One-third of adults experience low back pain
annually, whereas 53% of older adults have
symptomatic OA.1 2 Annually in the UK, one-
ﬁfth of people consult their general practi-
tioner for a musculoskeletal condition and 4%
of older adults consult for OA.3 Musculoskeletal
disorders were the largest cause of disability
globally in 2013.4
Strengths and limitations of this study
▪ The largest study to date of outcome following
treatment in a musculoskeletal Clinical and
Assessment Treatment Service.
▪ The participation rate at baseline was high and
the use of routinely collected consultation data
ensured high completion rates for the primary
outcome.
▪ Response to the postal follow-up questionnaires
was poor, particularly at 12 months.
▪ Questionnaire length permitted inclusion of only
generic measures of pain and physical function
rather than body region-specific measures which
might have been more sensitive to improvement.
▪ The study population was derived from a single
geographical region and did not include a com-
parator cohort which might limit the generalis-
ability of our findings.
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Most of these people are managed entirely in primary
care, with only a minority requiring specialist referral,
traditionally to hospital-based orthopaedic and rheuma-
tology services. Recently, patients requiring referral in
the UK are increasingly managed in multidisciplinary
Clinical Assessment and Treatment Services (CATS) at
the primary–secondary care interface.5 6 CATS act as a
one-stop shop, providing rapid access to assessment, diag-
nostic investigations, treatment by appropriately skilled
healthcare practitioners and onward referral pathways,
aiming to provide more integrated care, and prevent
chronicity, disability, and a cycle of reconsultation and
referral to multiple services across primary and secondary
care.5–7 We have previously shown that chronic pain, phys-
ical disability, anxiety, depression and work disability are
prevalent among patients attending a musculoskeletal
CATS, suggesting that these patients often already have
chronic pain and are not being identiﬁed early, emphasis-
ing the need for appropriate early referral pathways to
suitably skilled clinicians.8 Little is known about patient
outcome following treatment in this setting and if and
how patients subsequently reconsult.
The objectives of this prospective study were (1) to
determine the proportion of patients reconsulting in
primary care and in a musculoskeletal CATS in the
12 months following baseline assessment at the CATS,
(2) to assess baseline factors associated with reconsultation
in primary care and at the CATS, (3) to determine
change in self-reported health status at 6 and 12 months,
(4) to assess baseline factors associated with change in
self-reported health status and (5) to estimate the health-
care costs and quality-adjusted life-years (QALYs) over
6 months associated with CATS attendance and determine
whether these costs and QALYs differed by follow-up plan
at baseline.
METHODS
This was a prospective observational study set within a
musculoskeletal CATS in North Staffordshire, UK. The
methods and baseline cross-sectional ﬁndings have been
described previously.8 9
Study setting
At the time of baseline data collection, Stoke-on-Trent
Primary Care Trust (PCT) served a population of
>270 000 people. Referrals to secondary care musculo-
skeletal, rheumatology and orthopaedic services are
triaged by clinicians to a multidisciplinary, musculoskel-
etal CATS at the primary–secondary care interface fol-
lowing review of referral letters, so that musculoskeletal
conditions requiring non-surgical interventions are
managed in the community, while appropriate cases are
directed to rheumatology or orthopaedic services. The
CATS is the preferred provider for patients with non-
surgical, non-inﬂammatory musculoskeletal problems.
Patients are triaged to unselected general musculoskel-
etal clinics within the CATS, where the type of
healthcare professional patient seen (physiotherapist,
rheumatologist, rehabilitation medicine specialist or
GP with a special interest (GPwSI)) and the clinic in
which they are seen are not determined by the index
referred condition. The sole exception to this is a
physiotherapist-led back pain clinic. A greater propor-
tion of patients with back pain therefore see a physio-
therapist compared to other conditions.
Data collection
All adults aged ≥18 years seen at the CATS between
February 2008 and June 2009 were invited to participate.
Those who consented to take part completed a health
questionnaire prior to their CATS appointment.
Participants were also asked to provide consent for the
research team to review their medical records, which
provided data to answer the primary outcome of consult-
ation in primary care with the same musculoskeletal
problem within 12 months.
Baseline measures
The questionnaire included physical functioning and
body pain scales from the Short Form-36 (SF-36) V.2
(general population mean=50; scores <50 represent
worse health).10 Anxiety and depression were measured
using the Hospital Anxiety and Depression Scale (range
0–14; scores ≥8 on either scale representing possible or
probable anxiety or depression).11 The presence of pain
that interfered with daily activities was measured using
one item from the SF-36: ‘During the past 4 weeks, how
much did pain interfere with your normal work (includ-
ing both work outside the home and housework)?’.10
Respondents answering ‘moderately’, ‘quite a bit’ or
‘extremely’ were deﬁned as having pain interference,
while responding ‘quite a bit’ or ‘extremely’ represented
severe pain interference.12–14 Cohabitation status, self-
reported height/weight, musculoskeletal pain duration
and work absence in the preceding 6 months because of
musculoskeletal problems were also collected. The
EuroQoL-3L (EQ-5D 3L) was included, in order to cal-
culate QALYs.15
The clinician conducting the CATS consultation com-
pleted a brief proforma but did not see the patient’s
completed questionnaire. The clinician proforma
recorded the location of pain addressed in the consult-
ation (used to group participants into four mutually
exclusive categories: upper limb or neck alone, spine
alone, lower limb alone or multiple sites), investigations,
interventions, referrals and follow-up plan. Participants
were regarded as having pain in multiple sites if the clin-
ician recorded locations from two or more of the upper
limb/neck, spine or lower limb, or recorded a diagnosis
of ﬁbromyalgia, chronic widespread pain, generalised
OA or polymyalgia rheumatica. Follow-up was cate-
gorised as referral to other services (eg, rheumatology,
orthopaedics, physiotherapy), CATS follow-up, discharge
to the GP or to be decided following investigations. If
the follow-up plan was dependent on investigation
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results, follow-up information for those participants who
consented to medical record review was extracted from
CATS records. The clinician profession was also recorded.
Owing to the low number of rehabilitation medicine spe-
cialists, we combined these with rheumatologists (referred
to hereafter as hospital specialists). We also recorded
whether patients were attending a general musculoskel-
etal clinic or the physiotherapist-led back pain clinic
described above.
Follow-up questionnaires
A self-administered questionnaire containing the same
measures as at baseline was mailed at 6 and 12 months
to all consenting participants. Non-responders were sent
a postcard reminder after 2 weeks and a repeat question-
naire after 4 weeks.
Medical record review
In participants consenting to medical record review,
information was extracted from primary care records for
the 12 months following baseline. Owing to the large
number of general practices (n=114 including 49 with
fewer than 10 patients), it was unfeasible to examine the
records of all patients and so a pragmatic decision was
made to extract records from the 57 most accessible prac-
tices with the highest number of participants. Records
were downloaded electronically where possible but where
software was incompatible with the practice, information
was extracted manually using a proforma. The informa-
tion extracted was date of any musculoskeletal consult-
ation in primary care, and date of a musculoskeletal
consultation for the same body location (neck, shoulder,
elbow, hand/wrist, spine, hip, knee, foot/ankle) as
recorded by the clinician at baseline. Musculoskeletal
consultations were identiﬁed using the Read code system
which is commonly used to record morbidity in UK
primary care.16 Free-text narrative data were not extracted
from the medical record. We identiﬁed the date of any
further attendance at the CATS for the same body loca-
tion in all participants who consented to medical record
review through manual review of CATS records.
Sample size
At the time of baseline data collection, ∼3500 patients
were seen in the CATS annually. Based on previous
studies, we expected 75% of these to participate at base-
line (n=2625), and 75% of these to separately consent to
further postal contact and medical record review
(n=2000 each). While we aimed to review records of as
many patients as feasible, as an example, a sample size
of 1125 is sufﬁcient to determine the percentage
making a repeat primary care consultation during
12 months follow-up with a margin of error of 3% and a
95% conﬁdence level, based on an estimate of 50%.
Statistical analysis
We compared baseline responders with extracted
medical record data with all other baseline responders
on baseline sociodemographic, pain characteristics and
general health. The percentage consulting for a muscu-
loskeletal problem in primary care in the 12 months
after baseline was determined. The primary analysis was
based on the time to consulting in primary care about
the same body location which was addressed at the base-
line CATS consultation. We split time to ﬁrst consult-
ation to primary care into no consultation during
12-month follow-up, ﬁrst consultation within 3 months
(early), between 3 and 6 months, and between 6 and
12 months after baseline clinic assessment (late). We
used these categories rather than actual time as it was
evident that the baseline factors associated with ﬁrst
primary care attendance changed over the 12-month
time-period, and it was considered that attendance to
primary care within 3 months may be at the request of
the CATS clinician. Multinomial logistic regression was
used to determine the association of follow-up plan and
clinician profession with the time of consultation to
primary care adjusted for self-reported (age, gender,
cohabitation, pain interference and duration, body mass
index, anxiety and depression) and clinician-reported
(body region, musculoskeletal or back pain clinic)
factors. No repeat consultation was treated as the refer-
ence category. Results are reported as adjusted relative
risk ratios (RRR) with 95% CIs.
Secondary outcomes were reconsultation at the CATS
during 12-month follow-up and self-reported health
(physical function, body pain, anxiety and depression,
and time off work in those employed at baseline) at 6
and 12 months. Binary logistic regression was used to
assess association of clinician profession and follow-up
plan with reconsultation at the CATS about the same
body location as at the baseline clinic at any point
during the 12 months, adjusting for the same factors
included in the primary outcome analysis. Results are
presented as ORs with 95% CI. Multiple linear regres-
sion was used to assess the association of clinician profes-
sion and follow-up plan with physical function score at
follow-up adjusted for baseline score and for the same
baseline self-reported and clinician-reported factors as
included in the analysis of primary care consultation
(except pain interference as it was highly correlated
with baseline physical function).
Two sensitivity analyses were performed. First, as
primary care medical record information was not avail-
able for everyone, we performed multiple imputation
with 50 imputations and again repeated the analysis.
Second, because of the attrition at follow-up, the analysis
of self-reported physical function at 6 months was
repeated using multiple imputed data for those not
responding at follow-up.
Analysis of healthcare costs and QALYs
The health economic analysis was conducted from a
healthcare perspective and focused on estimating the
costs and QALYs arising from attending the CATS.
Resource use data were collected from the clinician
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proforma and 6-month questionnaire. The proforma
recorded investigations and interventions that patients
received, while the questionnaire asked about the
number and type of health professionals seen, medica-
tion taken and the number of interventions. Unit costs
for individual resource use items were obtained from
sources such as the British National Formulary (BNF),
Personal Social Services Research Unit and NHS refer-
ence costs.17–19 The analysis was limited to those who
completed the questionnaire. In order to value the
resource use items, we multiplied resource use by unit
costs and estimated a total cost per patient by summing
up the costs associated with each resource use item.
The area under the curve approach was used to esti-
mate QALYs using EQ-5D responses at baseline and
6 months. Multiple regression was used to estimate
mean total cost and QALYs by follow-up plan control-
ling for body region, age, body mass index (BMI),
Table 1 Associations with time after baseline assessment of first primary care consultation for musculoskeletal problem in
same body location as at baseline CATS consultation
0–3 months (early) 3–6 months 6–12 months (late)
Total consulting (% consulting) 507 (38) 289 (22) 114 (8) 104 (8)
n (% consulting) Adjusted RRR* (95% CI)
Male 586 (37) 1.00 1.00 1.00
Female 756 (38) 1.05 (0.79 to 1.42) 0.96 (0.64 to 1.46) 0.78 (0.51 to 1.20)
Age (years)
18–44 424 (37) 1.00 1.00 1.00
45–64 633 (38) 1.11 (0.80 to 1.55) 1.11 (0.68 to 1.81) 1.03 (0.63 to 1.70)
≥65 285 (38) 0.92 (0.60 to 1.41) 1.33 (0.75 to 2.36) 1.38 (0.77 to 2.48)
Living alone
No 1140 (38) 1.00 1.00 1.00
Yes 202 (39) 0.76 (0.49 to 1.18) 1.33 (0.79 to 2.23) 1.40 (0.80 to 2.45)
Professional seen
GPwSI 309 (29) 1.00 1.00 1.00
Hospital specialist 359 (39) 1.25 (0.82 to 1.92) 2.06 (1.13 to 3.75)† 2.08 (1.12 to 3.88)†
Physiotherapist 674 (41) 1.16 (0.77 to 1.73) 1.58 (0.88 to 2.84) 1.40 (0.76 to 2.60)
Region at clinic
Upper limb/neck 436 (32) 1.00 1.00 1.00
Spine 347 (52) 1.75 (1.09 to 2.82)† 1.12 (0.56 to 2.24) 2.17 (1.06 to 4.47)†
Lower limb 454 (31) 0.87 (0.60 to 1.28) 0.86 (0.53 to 1.41) 1.38 (0.81 to 2.36)
Multiple regions 105 (42) 1.16 (0.66 to 2.04) 0.97 (0.44 to 2.14) 1.77 (0.78 to 4.02)
Follow-up plan
Referred 492 (38) 1.00 1.00 1.00
Followed-up 145 (47) 1.28 (0.80 to 2.06) 1.28 (0.65 to 2.50) 0.86 (0.36 to 2.10)
Discharged 637 (35) 0.95 (0.69 to 1.30) 0.75 (0.48 to 1.17) 1.39 (0.87 to 2.21)
Unknown 68 (46) 1.40 (0.71 to 2.75) 1.29 (0.53 to 3.13) 1.87 (0.79 to 4.46)
Pain duration
<12 months 603 (37) 1.00 1.00 1.00
>12 months 738 (38) 0.80 (0.60 to 1.07) 0.91 (0.60 to 1.37) 1.28 (0.82 to 1.98)
Pain interference
No/little bit 300 (22) 1.00 1.00 1.00
Moderately 295 (29) 2.38 (1.37 to 4.14)† 1.07 (0.54 to 2.13) 0.72 (0.38 to 1.37)
Quite a bit/extremely 746 (47) 5.33 (3.23 to 8.80)† 2.26 (1.25 to 4.09)† 1.35 (0.78 to 2.33)
BMI
Normal 382 (35) 1.00 1.00 1.00
Overweight 484 (36) 1.18 (0.82 to 1.71) 0.77 (0.46 to 1.30) 1.07 (0.61 to 1.86)
Obese 439 (42) 1.28 (0.88 to 1.87) 1.16 (0.70 to 1.93) 1.63 (0.95 to 2.82)
Unknown 37 (38) 0.89 (0.35 to 2.23) 1.37 (0.47 to 3.94) 0.86 (0.19 to 3.97)
Anxious/depressed
No 606 (34) 1.00 1.00 1.00
Yes 736 (41) 1.02 (0.75 to 1.40) 0.97 (0.62 to 1.50) 0.60 (0.38 to 0.95)†
Bold typeface denotes statistical significance.
Percentages are row percentages.
*Multinomial logistic regression n=1340 (two participants omitted due to missing data). RRR adjusted for all presented variables and type of
clinic attended (general musculoskeletal or physiotherapist-led back pain clinic), reference group is no musculoskeletal consultation.
†p<0.05.
BMI, body mass index; CATS, Clinical and Assessment Treatment Service; GPwSI, general practitioner with a special interest; RRR, relative
risk ratios.
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anxiety and depression, pain interference and baseline
EQ-5D. Bootstrapping (1000 replications) was used to
estimate bias-corrected CIs around differences in mean
costs and QALYs between groups using patients who
were referred to other specialities as the reference
category.
RESULTS
As reported previously,8 3429 patients were mailed the
baseline questionnaire of whom 453 (13%) did not
attend their CATS appointment. Two thousand one
hundred and sixty-six consented to participate at baseline,
from whom 2116 clinician proformas were completed
(adjusted response 71%). Of these, 1453 (69%) had their
medical records reviewed and did not have a primary
care musculoskeletal consultation on the same day as
their CATS appointment (see online supplementary
ﬁgure S1). Compared to those responding but not under-
going record review, these participants were older (mean
difference 2.6 years, 95% CI 1.3 to 4.0) and had slightly
worse levels of pain, but no differences on gender,
Table 2 Associations with return to interface clinic during 12-month follow-up for musculoskeletal problem in same body
location as baseline CATS consultation
Total n (% with appointment) OR (95% CI) Adjusted OR* (95% CI)
Total 1342 (26)
Male 586 (25) 1.00 1.00
Female 756 (26) 1.07 (0.84 to 1.28) 1.10 (0.83 to 1.45)
Age (years)
18–44 424 (23) 1.00 1.00
45–64 633 (27) 1.23 (0.93 to 1.64) 1.35 (0.98 to 1.86)
≥65 285 (27) 1.21 (0.86 to 1.71) 1.41 (0.95 to 2.09)
Living alone
No 1140 (26) 1.00 1.00
Yes 202 (23) 0.83 (0.58 to 1.18) 0.89 (0.60 to 1.32)
Professional seen
GPwSI 309 (23) 1.00 1.00
Hospital specialist 359 (26) 1.15 (0.81 to 1.64) 1.68 (1.14 to 2.49)†
Physiotherapist 674 (27) 1.20 (0.88 to 1.64) 0.91 (0.62 to 1.34)
Region at clinic
Upper limb/neck 436 (27) 1.00 1.00
Spine 347 (35) 1.48 (1.09 to 2.01)† 0.84 (0.53 to 1.35)
Lower limb 454 (17) 0.54 (0.39 to 0.75)† 0.59 (0.41 to 0.83)†
Multiple regions 105 (30) 1.14 (0.71 to 1.83) 1.05 (0.63 to 1.77)
Follow-up plan
Referred 492 (17) 1.00 1.00
Followed-up 145 (68) 10.61 (6.96 to 16.17)† 9.97 (6.36 to 15.62)†
Discharged 637 (23) 1.50 (1.12 to 2.03)† 1.54 (1.13 to 2.10)†
Unknown 68 (21) 1.28 (0.68 to 2.41) 1.19 (0.62 to 2.29)
Pain duration
<12 months 603 (27) 1.00 1.00
>12 months 738 (24) 0.85 (0.66 to 1.09) 0.75 (0.57 to 0.99)†
Pain interference
No/little bit 300 (19) 1.00 1.00
Moderately 295 (25) 1.49 (1.00 to 2.20)† 1.53 (1.00 to 2.35)
Quite a bit/extremely 746 (29) 1.75 (1.26 to 2.44)† 1.64 (1.11 to 2.42)†
BMI
Normal 382 (25) 1.00 1.00
Overweight 484 (26) 1.03 (0.76 to 1.41) 1.10 (0.78 to 1.55)
Obese 439 (26) 1.06 (0.77 to 1.44) 1.12 (0.79 to 1.58)
Unknown 37 (16) 0.57 (0.23 to 1.40) 0.45 (0.17 to 1.22)
Anxious/depressed
No 606 (25) 1.00 1.00
Yes 736 (26) 1.06 (0.83 to 1.36) 0.92 (0.68 to 1.23)
Bold typeface denotes statistical significance.
Percentages are row percentages.
*Binary logistic regression n=1340 (two participants omitted due to missing data). Adjusted for all presented variables and type of clinic
attended (general musculoskeletal or physiotherapist-led back pain clinic), referent group is no follow-up appointment.
†p<0.05.
BMI, body mass index; CATS, Clinical and Assessment Treatment Service; GPwSI, general practitioner with a special interest.
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anxiety, depression, physical functioning, pain duration,
pain interference, employment status or time off work
(see online supplementary table S1).
Consultation in primary care during 12-month follow-up
Of the 1453 for whom record data were collected, 1342
were included in the primary outcome analysis as the
remainder received other diagnoses such as gout,
inﬂammatory arthritis and joint hypermobility, and
hence, a speciﬁc body region was not available to link
subsequent consultations to (see online supplementary
ﬁgure S1). Of these, 507 (38%, 95% CI 35% to 40%)
consulted primary care during 12-month follow-up for
the same body region as addressed at the baseline clinic
assessment. Median number of days to consulting
primary care was 69 (IQR 27 to 159): 289 (22%) con-
sulted within 3 months and 403 (30%) within 6 months.
There was no association between the type of profes-
sional seen at baseline and consulting in the ﬁrst
3 months but those seeing a hospital specialist were
more likely to ﬁrst return to primary care between 3 and
6 months after their CATS visit (adjusted RRR 2.06; 95%
CI 1.13 to 3.75 compared to GPwSI) and between 6 and
12 months (2.08; 1.12 to 3.88) (table 1). The strongest
association with consulting within the ﬁrst 6 months was
with severe pain interference at baseline (within
3 months: 5.33; 3.23 to 8.80 compared to no pain inter-
ference; 3–6 months: 2.26; 1.25 to 4.09). Those consulting
with a spine problem were more likely to consult primary
care in the ﬁrst 3 months (1.75; 1.09 to 2.82) or after 6–
12 months (2.17; 1.06 to 4.47) compared to having an
upper limb or neck problem. Those with anxiety or
depression were less likely to ﬁrst consult primary care
between 6 and 12 months (0.60; 0.38 to 0.95). There was
no association of gender, cohabitation status, follow-up
plan, pain duration or BMI with primary care
consultation.
Analysis based on multiple imputation data yielded
similar estimates and CIs to those from the analysis for
those whose records were reviewed.
Reconsultation at the CATS during 12-month follow-up
Three hundred and forty-ﬁve (26%) reconsulted at the
CATS during 12-month follow-up for a musculoskeletal
problem in the same body location as assessed at base-
line. The clinician stating they would follow-up the
patient (adjusted OR 9.97; 95% CI 6.36 to 15.62) was
most strongly associated with reconsultation at the CATS
while being discharged (1.54; 1.13 to 2.10) was also sig-
niﬁcantly associated (table 2). Patients seeing a hospital
specialist were more likely to reconsult in the CATS (OR
1.68; 95% CI 1.14 to 2.49 compared to GPwSI). Severe
pain interference and shorter pain duration were also
associated with reconsultation.
Self-reported health and time off work
One thousand one hundred and forty-three (54%) of
the 2116 baseline responders with a completed clinician
proforma completed the follow-up questionnaire at
6 months and 762 (36%) at 12 months. Six-month re-
sponders were older (mean age 54.9 vs 46.4) compared
to non-responders and had lower levels of anxiety and
depression. However, they did not differ according to
pain, physical function or the type of clinician seen at
baseline. Responders showed some improvement at
6 months in body pain (mean change 3.86; 95% CI 3.38
to 4.34; effect size equivalent 0.47), whereas a smaller
change was seen in physical functioning (mean change
1.88; 95% CI 1.44 to 2.32; effect size equivalent 0.16)
(table 3). The percentage with severe pain interference
Table 3 Self-reported change in physical and mental health status, time off work and pain interference at 6 and 12 months
Baseline* 6 months 12 months
Mean (SD) Mean change† (95% CI) Mean change† (95% CI)
HADS depression 6.1 (4.2) −0.02 (−0.20 to 0.16) −0.13 (−0.35 to 0.09)
HADS anxiety 7.5 (4.6) 0.03 (−0.16 to 0.22) −0.02 (−0.26 to 0.22)
SF-36 physical function 36.4 (11.9) 1.88 (1.44 to 2.32) 1.82 (1.24 to 2.39)
SF-36 body pain 34.5 (8.3) 3.86 (3.38 to 4.34) 4.19 (3.55 to 4.83)
n (%) n (%) n (%)
Time off work‡ 219 (42) 169 (33) 110 (33)
Anxious/depressed 588 (53) 591 (53) 390 (52)
Pain interference
Not at all/a little 258 (23) 429 (38) 284 (38)
Moderately 261 (23) 247 (22) 178 (24)
Quite a bit/extremely 606 (54) 449 (40) 289 (38)
Bold typeface denotes statistical significance.
Number in analysis for baseline and 6 months: 1118 (depression), 1115 (anxiety), 1124 (physical function), 1109 (body pain), 519 (time off
work), 1115 (anxiety/depression), 1125 (interfering pain). Number in analysis for 12 months: 748 (depression), 748 (anxiety), 754 (physical
function), 745 (body pain), 332 (time off work), 748 (anxiety/depression), 751 (interfering pain).
*In those responding at 6 months.
†Positive mean change indicates improvement.
‡In those currently employed at baseline n=519. At 6 and 12 months, time off work includes those no longer employed.
HADS, Hospital Anxiety and Depression Scale; SF-36, Short Form-36.
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fell from 54% to 40% at 6 months, while the percentage
taking time off work due to their musculoskeletal
problem fell from 42% to 33%. However, there was no
change in anxiety or depression levels, nor was there
any further change in any of these measures at
12 months. Given the high attrition at 12 months, and
the lack of change at the population level between 6
and 12 months, the remainder of the self-reported ana-
lysis concentrated on the 6-month time-point.
Type of clinician seen and follow-up plan did not asso-
ciate with physical function at 6 months (table 4).
Females, older adults, those who were obese, those with
pain duration of >12 months and those with worse phys-
ical function at baseline had the worst outcomes at
6 months. For example, those with pain duration longer
than 12 months at baseline had a mean physical func-
tioning score at 6 months around 2 points worse than
those with shorter pain duration (adjusted mean differ-
ence −1.93; 95% CI −2.83 to −1.03). Sensitivity analysis
based on multiple imputation data made little difference
to these estimates and CIs.
Healthcare costs and QALYs
The overall mean (SD) cost per patient incurred by
attending the CATS was £422.40 (660.11) over the
6-month period. The mean cost associated with patients
who were discharged was signiﬁcantly lower than those
who were referred to other specialities (mean differ-
ence £−132.57; 95% CI −226.78 to −49.54) (table 5).
Costs associated with patients in the other groups
(followed-up and unknown) were not signiﬁcantly dif-
ferent from costs associated with patients who were
referred (table 5).
Across all participants, the mean (SD) QALYs per
patient over the 6-month period was 0.257 (0.144).
There was no signiﬁcant difference in mean QALYs
between patients who were referred to other specialities
and any other group.
DISCUSSION
After assessment in a musculoskeletal CATS, nearly 40%
of people consulted primary care about the same
problem within 12 months, with over half of these con-
sulting within 3 months. Similarly, a quarter of patients
reconsult in the CATS within 12 months. People with
pain interference and spinal pain were more likely to
reconsult. Over 6 months, only small changes were seen
in body pain and physical function, and in the propor-
tion reporting pain interference and taking time off
Table 4 Six-month follow-up PF score by baseline factors
Adjusted for baseline PF score only
Coefficient (95% CI)
Adjusted for all variables
Coefficient (95% CI)
Female (referent: male) −0.84 (−1.73 to 0.06) −0.90 (−1.80 to 0.00)*
Age (years) (referent: 18–44)
45–64 −1.41 (2.50 to −0.33) −1.27 (−2.36 to −0.17)*
≥65 −2.94 (−4.21 to −1.67)* −2.87 (−4.19 to −1.55)*
Living alone (referent: not living alone) −1.14 (−2.37 to 0.09) −0.53 (−1.77 to 0.72)
Professional seen (referent: GPwSI)
Hospital specialist 0.05 (−1.17 to 1.27) −0.24 (−1.45 to 0.97)
Physiotherapist 0.69 (−0.40 to 1.77) −0.32 (−1.48 to 0.84)
Region at clinic (referent: upper limb/neck)
Spine 2.02 (0.82 to 3.21)* 0.52 (−1.02 to 2.05)
Lower limb −0.05 (−1.20 to 1.10) −0.47 (−1.62 to 0.68)
Multiple regions −0.34 (−1.89 to 1.20) −0.58 (−2.13 to 0.96)
Other 0.07 (−2.10 to 2.23) −0.72 (−2.87 to 1.43)
Follow-up plan (referent: referred)
Followed-up 0.05 (−1.45 to 1.56) −0.91 (−2.45 to 0.63)
Discharged 0.23 (−0.75 to 1.21) 0.12 (−0.85 to 1.09)
Unknown −0.48 (−2.26 to 1.30) −0.58 (−2.33 to 1.17)
Pain duration >12 months (referent <12 months) −1.99 (−2.90 to −1.09)* −1.93 (−2.83 to −1.03)*
BMI (referent: normal BMI)
Overweight 0.30 (−0.77 to 1.36) 0.17 (−0.89 to 1.22)
Obese −1.59 (−2.75 to −0.43)* −1.58 (−2.74 to −0.43)*
Unknown −1.65 (−4.38 to 1.08) −1.09 (−3.80 to 1.63)
Anxious/depressed (referent: not anxious/depressed) −0.65 (−1.59 to 0.29) −0.81 (−1.75 to 0.12)
Baseline PF score† 0.87 (0.82 to 0.92)* 0.79 (0.75 to 0.84)*
Bold typeface denotes statistical significance.
Coefficient is adjusted mean difference in PF score at follow-up compared to referent, with positive coefficient indicating higher (better) PF
score, complete data only, n=1124.
*p<0.05.
†Per unit PF score at baseline.
BMI, body mass index; GPwSI, general practitioner with a special interest, PF, physical functioning.
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work because of their musculoskeletal problem.
Functional outcome was worst in those with older age,
obesity, chronicity and pre-existing physical impairment.
The cost-outcome description found that follow-up plan
to see again in the CATS or to refer to another specialty
attracted higher mean costs.
The explanations for frequent reconsultation are
likely to be multifactorial, and our study design cannot
elucidate these. It may be that patients were advised to
visit their GP for change in medication, they recon-
sulted to obtain a repeat prescription, the CATS con-
sultation failed to adequately meet patients’
expectations and/or their symptoms did not improve.
The observation that patients assessed by hospital spe-
cialists were more likely to reconsult could be explained
by specialists advising further consultation in primary
care, for example, to change medication, rather than
this reﬂecting poor outcome. The ﬁndings that people
with pain interference (either setting) and spinal pain
(primary care) were more likely to consult and worse
functional outcome was associated with older age,
obesity, chronicity and pre-existing physical impairment
suggest that the current model of care does not meet
the needs of those with the most troublesome symp-
toms. An unexpected ﬁnding that we ﬁnd difﬁcult to
explain was that people with anxiety or depression were
less likely to ﬁrst consult primary care between 6 and
12 months.
There are few suitable cohorts to compare our ﬁnd-
ings to. In a study undertaken in a physiotherapist-led
CATS, small improvements were reported in pain and
general health (EQ-5D) over 12 months but no change
was seen in the SF-36.20 Most improvement occurred
within 3 months but was less likely in people with spinal
pain and chronic symptoms. Repeat consultation was
not examined. Several studies have found similar rates
of repeat musculoskeletal consultations in primary care
following an initial primary care consultation.
One-third to one-half of primary care shoulder pain
consulters in Scandinavia reconsult within 12
months.21 22 We have previously shown that 34% of
knee pain consulters and 22% of foot pain consulters
consult again in primary care with the same problem
over 18 months.23 24
This is the largest study to date of outcome following
treatment in musculoskeletal CATS. Strengths of the
study are the high participation rate at baseline (73%)
and the use of routinely collected consultation data to
ensure high completion rates for the primary outcome.
Several limitations are, however, worthy of further discus-
sion. First, the response to the postal follow-up question-
naires was poor, particularly at 12 months. However,
questionnaire data were used to answer the secondary
objectives rather than the primary objective which used
data from consultation records, available for 69% of
baseline responders. Furthermore, a sensitivity analysis
using multiple imputation to account for loss to
follow-up did not signiﬁcantly alter our ﬁndings.
Second, pain and physical function were measured
using generic health status instruments, ﬁnding only
small changes over time. Owing to questionnaire length,
we could not include body region-speciﬁc questionnaires
which might have been more sensitive to improvement.
Third, the study population was derived from a single
geographical region and participants recruited from a
single CATS which might limit the generalisability of our
ﬁndings. Finally, we did not include a comparator
cohort to allow a direct comparison to patients managed
in other settings such as primary care, orthopaedics or
rheumatology.
Our ﬁndings suggest that musculoskeletal CATS
should be conﬁgured to address troublesome disabling
pain since it is patients with the most bothersome symp-
toms who are most likely to reconsult either in primary
care or at the CATS and to experience poor functional
outcome. We have previously highlighted the complex-
ity of patients referred from primary care to musculo-
skeletal CATS, showing chronic pain, major physical
limitation, anxiety, depression and work disability to be
highly prevalent.8 Our ﬁnding that poor outcome is
associated with pain interference, obesity, pain dur-
ation and physical impairment raises the possibility
that targeting speciﬁc treatments at people with
certain modiﬁable risk factors might improve outcome,
as has been shown to be the case in other settings, for
example, stratiﬁed care using the STarT Back tool in
people with low back pain in primary care.25 However,
further research is needed to determine how to
Table 5 Mean costs and QALYs over 6 months according to follow-up plan
Mean cost* Mean difference (95% CI)† Mean QALYs* Mean difference (95% CI)†
Referred (n=405) £497.55 0.2572
Followed-up (n=124) £437.18 £−60.37 (−172.68 to 67.36)‡ 0.2566 −0.001 (−0.014 to 0.014)‡
Discharged (n=526) £364.98 £−132.57§ (−226.78 to −49.54)‡ 0.2591 0.002 (−0.006 to 0.009)‡
Unknown (n=82) £397.23 £−100.32 (−227.19 to 93.92)‡ 0.2498 −0.007 (−0.020 to 0.005)‡
*Values are predicted means obtained from multiple regression controlling for body region, age, body mass index, anxiety, depression, pain
interference and baseline EQ-5D.
†Compared to patients who were referred.
‡Bootstrapped CI.
§p<0.05.
QALYs, quality-adjusted life-years.
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identify people at risk of poor outcome from musculo-
skeletal problems and evaluate what targeted treatment
should consist of. Notwithstanding this important
future research agenda, we suggest that musculoskel-
etal services need to be resourced to provide a biopsy-
chosocial model of care, with appropriately trained
clinical staff, and that services need the ﬂexibility and
resource to offer follow-up appointments, where clinic-
ally indicated, in order to monitor progress, tailor
treatment to the individual and address clinical
complexity.
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